Kayla Shumate, PhD

Principal Scientist, Bioanalytics and DMPK

Kayla Shumate, PhD, serves as Principal Scientist, Bioanalysis and DMPK at Hemab. She has over a decade of research experience spanning translational sciences, from nonclinical and clinical assay development and CRO management to animal model generation and biomarker identification. Most recently, Kayla served as a Scientist and Bioanalytical Lead at AskBio, with previous experience at Biogen. She received a PhD in Pharmacology from Vanderbilt University in Nashville, TN.

Meet the Team

Hemab unites experts in clotting, patient care, and drug development to transform the lives of people with bleeding disorders

Leadership
Board
Team
Investors
Access Biotechnology
Avoro Ventures
Deep Track Capital
HealthCap
Invus
Maj Invest Equity
Novo Holdings
RA Capital
Rock Springs Capital
Sofinnova Partners
Hemab team photo
Hemab icon in larger circles

We’re building the ultimate clotting company.